Phase Holographic Imaging PHI AB (FRA:L5W) Cash Ratio: 0.53 (As of Oct. 2025) — 76% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Phase Holographic Imaging PHI AB Cash Ratio?

Phase Holographic Imaging PHI AB FRA:L5W Cash Ratio is 0.53 as of Oct. 2025, which is 76% below its 10-year median of 2.22. The stock has 5 warning signs investors should review.

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Phase Holographic Imaging PHI AB's Cash Ratio for the quarter that ended in Oct. 2025 was 0.53.

Phase Holographic Imaging PHI AB has a Cash Ratio of 0.53. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for Phase Holographic Imaging PHI AB's Cash Ratio or its related term are showing as below:

FRA:L5W' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 2.22   Max: 8.82
Current: 0.53

During the past 13 years, Phase Holographic Imaging PHI AB's highest Cash Ratio was 8.82. The lowest was 0.01. And the median was 2.22.

FRA:L5W's Cash Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.95 vs FRA:L5W: 0.53

Phase Holographic Imaging PHI AB  (FRA:L5W) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Phase Holographic Imaging PHI AB Cash Ratio Related Terms


Phase Holographic Imaging PHI AB Cash Ratio Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB Cash Ratio Chart

Phase Holographic Imaging PHI AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.20 0.51 0.02 2.79

Phase Holographic Imaging PHI AB Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 2.83 2.79 2.24 0.53

FRA:L5W vs ABT, BSX, SYK: Cash Ratio Comparison

For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phase Holographic Imaging PHI AB Cash Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Phase Holographic Imaging PHI AB's Cash Ratio falls into.



Phase Holographic Imaging PHI AB Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Phase Holographic Imaging PHI AB's Cash Ratio for the fiscal year that ended in Apr. 2025 is calculated as:

Cash Ratio (A: Apr. 2025 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.316/0.472
=2.79

Phase Holographic Imaging PHI AB's Cash Ratio for the quarter that ended in Oct. 2025 is calculated as:

Cash Ratio (Q: Oct. 2025 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.202/0.382
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Ratio →
What does a Cash Ratio of 0.53 mean?
Phase Holographic Imaging PHI AB (FRA:L5W) has a Cash Ratio of 0.53 as of Oct. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Phase Holographic Imaging PHI AB and its competitors. This is 76% below median its historical median of 2.22. Over the past decade, Phase Holographic Imaging PHI AB's Cash Ratio has ranged from 0.01 to 8.82.
Is Phase Holographic Imaging PHI AB's Cash Ratio too high?
Phase Holographic Imaging PHI AB's current Cash Ratio of 0.53 is 76% below median its 10-year median of 2.22. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 8.82. The Medical Devices & Instruments industry median Cash Ratio is 0.95. Phase Holographic Imaging PHI AB's value of 0.53 is 44.2% below this industry median.
How does Phase Holographic Imaging PHI AB's Cash Ratio compare to ABT and BSX?
Phase Holographic Imaging PHI AB's Cash Ratio of 0.53 can be compared against companies in the Medical Devices & Instruments industry. The industry median Cash Ratio is 0.95. Phase Holographic Imaging PHI AB's value of 0.53 is 44.2% below this benchmark. Historically, Phase Holographic Imaging PHI AB's own Cash Ratio has ranged from 0.01 to 8.82 over the past decade. While the company's 10-year median is 2.22 vs. the industry median of 0.95, Phase Holographic Imaging PHI AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.95, based on 833 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phase Holographic Imaging PHI AB's current Cash Ratio of 0.53 is 44.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current Cash Ratio is 0.53, which is 76% below median its own 10-year median of 2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current Cash Ratio of 0.53. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current Cash Ratio is 0.53, which is 76% below median its 10-year median of 2.22 and 44.2% below the Medical Devices & Instruments industry median of 0.95. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current Cash Ratio is 0.53 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phase Holographic Imaging PHI AB Business Description

Address Skiffervagen 48, Lund, SWE, 224 78
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.